TheraRadar
← Back
Data updated: Mar 29, 2026

INSMED INC

RespiratoryInfectious DiseaseCardiovascular
Pharma

INSMED INC is a pharmaceutical company focused on Respiratory, Infectious Disease, Cardiovascular. Key products include ARIKAYCE KIT.

2005
Since
3
Drugs
-
Trials
2
Approved (2yr)

Key Drugs

ARIKAYCE KIT
amikacin sulfate
Ribosome 9 indications · 2018
BRINSUPRI
brensocatib
DPP1 1 indications · 2025

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

ARIKAYCE KIT 2025-12-05
Labeling
BRINSUPRI 2025-08-12
Type 1 - New Molecular Entity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Respiratory 36%
0 drugs Phase 3: 3 Phase 2: 7
Infectious Disease 30%
1 drugs Phase 3: 4
Cardiovascular 25%
0 drugs Phase 3: 2 Phase 2: 5
Dermatology 8%
1 drugs
Gastroenterology 1%
0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Gastroenterology, Respiratory
Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Dermatology, Respiratory
B BRAUN specialty
Infectious Disease, Dermatology, Cardiovascular